Trial Profile
A Randomized, Multi-Center, Double-Masked, Vehicle-Controlled, Parallel-Group, Safety and Efficacy Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle for Four Weeks in Subjects With Blepharitis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Blepharitis
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 19 Sep 2014 New trial record